PubMed

Adherence to protease inhibitors.

Murri R, Ammassari A, Antinori A.

Ann Intern Med. 2001 Apr 3;134(7):625. No abstract available. PMID: 11281748 [PubMed - indexed for MEDLINE]Related articlesFree article

[Discontinuation of antiretroviral treatment containing a protease inhibitor. Failure and tolerance]

Michelet C.

Presse Med. 1999 Feb 27;28(8):402-4. French. No abstract available. PMID: 10093600 [PubMed - indexed for MEDLINE]Related articles

Drug-resistant genotyping in HIV-1 therapy.

Spire B, Souville M.

Lancet. 1999 Sep 25;354(9184):1121. No abstract available. PMID: 10509524 [PubMed - indexed for MEDLINE]Related articles

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy.

Pozniak A, Gazzard B, Anderson J, Babiker A, Churchill D, Collins S, Fisher M, Johnson M, Khoo S, Leen C, Loveday C, Moyle G, Nelson M, Peter B, Phillips A, Pillay D, Wilkins E, Williams I, Youle M; BHIVA Writing Committee BHIVA Executive Committee.

HIV Med. 2003 Oct;4 Suppl 1:1-41. No abstract available. PMID: 14511246 [PubMed - indexed for MEDLINE]Related articles

Medication adherence in patients with HIV infection: a comparison of two measurement methods.

Melbourne KM, Geletko SM, Brown SL, Willey-Lessne C, Chase S, Fisher A.

AIDS Read. 1999 Aug;9(5):329-38.PMID: 12737122 [PubMed - indexed for MEDLINE]Related articles

Why switch from protease inhibitors (PI) to non-nucleoside reverse transcriptase inhibitors (NNRTI)?

Pozniak AL.

HIV Med. 2000;1 Suppl 1:7-10. Review. No abstract available. PMID: 11737361 [PubMed - indexed for MEDLINE]Related articles

Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors.

Knobel H, Guelar A, Carmona A, Espona M, González A, López-Colomés JL, Saballs P, Gimeno JL, Díez A.

AIDS Patient Care STDS. 2001 Apr;15(4):193-9.PMID: 11359661 [PubMed - indexed for MEDLINE]Related articles

The efficacy of lopinavir in individuals experiencing protease inhibitor failure.

Gilleece YC, Qazi NA, Morlese JF, Mandalia S, Gazzard BG, Pozniak AL, Nelson MR.

J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):238-40. No abstract available. PMID: 12571536 [PubMed - indexed for MEDLINE]Related articles

Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with hiv-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled study.

Ruiz L, Negredo E, Domingo P, Paredes R, Francia E, Balagué M, Gel S, Bonjoch A, Fumaz CR, Johnston S, Romeu J, Lange J, Clotet B; Spanish Lipodystrophy Group.

J Acquir Immune Defic Syndr. 2001 Jul 1;27(3):229-36.PMID: 11464141 [PubMed - indexed for MEDLINE]Related articles

Preclinical data released on PI.

[No authors listed]

AIDS Patient Care STDS. 2003 Sep;17(9):483-4. No abstract available. PMID: 14596252 [PubMed - indexed for MEDLINE]Related articles

Resistance data on 908.

[No authors listed]

AIDS Patient Care STDS. 2003 Sep;17(9):483. No abstract available. PMID: 14588086 [PubMed - indexed for MEDLINE]Related articles

Reduced levels of CD4 cell spontaneous apoptosis in human immunodeficiency virus-infected patients with discordant response to protease inhibitors.

Meroni L, Varchetta S, Manganaro D, Gatti N, Riva A, Monforte A, Galli M.

J Infect Dis. 2002 Jul 1;186(1):143-4. No abstract available. PMID: 12089680 [PubMed - indexed for MEDLINE]Related articles

Are nonnucleoside analogue-based regimens better than protease inhibitor-based regimens for nonadherent HIV-infected patients?

Knobel H.

Clin Infect Dis. 2005 Jan 1;40(1):164-6. Epub 2004 Dec 6. No abstract available. PMID: 15614707 [PubMed - indexed for MEDLINE]Related articles

Combination drug therapy for the human immunodeficiency virus (HIV)

[No authors listed]

J Am Osteopath Assoc. 1997 Mar;97(3):128. No abstract available. PMID: 9107121 [PubMed - indexed for MEDLINE]Related articles

Patient adherence, not viral load now most important in HIV therapy.

[No authors listed]

Rep Med Guidel Outcomes Res. 2000 Feb 3;11(3):6-7. No abstract available. PMID: 11768406 [PubMed - indexed for MEDLINE]Related articles

Half-full or half-empty: no simple answer on protease inhibitor failure.

Torres G.

GMHC Treat Issues. 1997 Oct;11(10):1-2.PMID: 11364818 [PubMed - indexed for MEDLINE]Related articles

Characteristics of HIV antiretroviral treatments, access and adherence in an ethnically diverse sample of men who have sex with men.

Halkitis PN, Parsons JT, Wolitski RJ, Remien RH.

AIDS Care. 2003 Feb;15(1):89-102.PMID: 12655837 [PubMed - indexed for MEDLINE]Related articles

Long-term strategies: should some patients wait to start protease inhibitors? Interview with Keith Henry, M.D. Interview by John S. James.

Henry K.

AIDS Treat News. 1997 Oct 17;(No 281):1, 3-6.PMID: 11364791 [PubMed - indexed for MEDLINE]Related articles

Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized study.

Røge BT, Barfod TS, Kirk O, Katzenstein TL, Obel N, Nielsen H, Pedersen C, Mathiesen LR, Lundgren JD, Gerstoft J.

HIV Med. 2004 Sep;5(5):344-51.PMID: 15369509 [PubMed - indexed for MEDLINE]Related articles

Resistance and other factors involved in therapy failure.

Mallol S.

Antivir Ther. 2001;6 Suppl 2:21-7. No abstract available. PMID: 11678475 [PubMed - indexed for MEDLINE]Related articles